Our core services

PRMA Consulting are experts in pricing, reimbursement, and market access. We work in close partnership with our clients to deliver integrated and innovative solutions to market access.

Market access

Development of value strategy based on in-depth understanding of HTA/P&R evidence and methodological requirements, with critical insight from payors and clinicians

Learn more

Pricing & reimbursement

Primary and secondary research to understand the current and likely future landscape and inform the value proposition and P&R strategy

Learn more

Economic models & evidence synthesis

Development of methodologically robust economic models and evidence synthesis according to HTA agency requirements

Learn more

Patient-reported outcomes

Strategies to optimize the generation of patient-centered outcomes data to support the value proposition to regulators, reimbursement agencies, and patients

Learn more

Real-world evidence

Quantitative research into treatment, disease burden, and resource use to inform multiple elements of the market access strategy

Learn more

Personalized medicine

In-depth understanding of the complexities and challenges around market access for companion diagnostic–drug pairings

Learn more

Conferences and events

We regularly host webinars and attend international conferences, meet us online or face to face to discuss your market access issues

Learn more

PRMA Insights syndicated reports

Developed by industry-experienced experts, these reports provide in-depth understanding of current and future market access realities

Learn more

Forthcoming events

Unlocking the market access potential of immuno-oncology agents

Available online >>

Our hematology experts will be at ECCO/ESMO 25–29 Sep

Meet with us >>

Our experts will be at ISPOR EU from 07 Nov–11 Nov

Meet with us >>

Our hematology experts will be at ASH from 05 Dec–08 Dec

Meet with us >>

Syndicated reports

PRMA Insights: Pricing and Reimbursement Success are key resources for planning your market access strategy

AMNOG syndicated report


PRMA Insights Focus: The Impact of AMNOG on Pricing & Reimbursement in Germany and Beyond

Learn more >>

Companion diagnostics in oncology syndicated report

Companion diagnostics

PRMA Insights: Market Access Success for Companion Diagnostic–Drug Pairings in Oncology

Learn more >>

NSCLC syndicated report


PRMA Insights: Pricing & Reimbursement Success in NSCLC

Learn more >>

Metastatic breast cancer syndicated report

Metastatic breast cancer

PRMA Insights: Pricing & Reimbursement Success in Metastatic Breast Cancer

Learn more >>

Renal cell carcinoma syndicated report

Renal cell carcinoma

PRMA Insights: Pricing & Reimbursement Success in Renal Cell Carcinoma

Learn more >>

Rheumatoid arthritis syndicated report

Rheumatoid arthritis

PRMA Insights: Pricing & Reimbursement Success in Rheumatoid Arthritis

Learn more >>

Psoriasis syndicated report


PRMA Insights: Pricing & Reimbursement Success in Psoriasis

Learn more >>

COPD syndicated report


PRMA Insights: Pricing & Reimbursement Success in COPD

Learn more >>

"PRMA Consulting is the best consultancy we've worked with in every way – flexibility, responsiveness, adherence to timelines and quality of the work."
Head of Market Access, Health Economics, and Pricing – top-30 global pharmaceutical company